Identity
HGNC
LOCATION
2q36.1
LOCUSID
ALIAS
CHGC,EM66,SN,SgII
FUSION GENES
Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 7857
MIM: 118930
HGNC: 10575
Ensembl: ENSG00000171951
Variants:
dbSNP: 7857
ClinVar: 7857
TCGA: ENSG00000171951
COSMIC: SCG2
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000171951 | ENST00000305409 | P13521 |
| ENSG00000171951 | ENST00000421386 | C9JQI2 |
| ENSG00000171951 | ENST00000433889 | C9JDT0 |
Expression (GTEx)
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 37848672 | 2024 | Promoting effect and immunologic role of secretogranin II on bladder cancer progression via regulating MAPK and NF-κB pathways. | 0 |
| 38184555 | 2024 | Circulating secretoneurin level reflects angiographic coronary collateralization in stable angina patients with chronic total occlusion. | 0 |
| 38261566 | 2024 | Prognostic value of plasma secretoneurin concentration in patients with heart failure with reduced ejection fraction in one-year follow-up. | 0 |
| 37848672 | 2024 | Promoting effect and immunologic role of secretogranin II on bladder cancer progression via regulating MAPK and NF-κB pathways. | 0 |
| 38184555 | 2024 | Circulating secretoneurin level reflects angiographic coronary collateralization in stable angina patients with chronic total occlusion. | 0 |
| 38261566 | 2024 | Prognostic value of plasma secretoneurin concentration in patients with heart failure with reduced ejection fraction in one-year follow-up. | 0 |
| 37023080 | 2023 | Investigation of secretoneurin as a potential biomarker of brain injury in very preterm infants: A pilot study. | 1 |
| 37933640 | 2023 | [High expression of secretogranin II increases oxaliplatin resistance of colorectal cancer cells]. | 0 |
| 37023080 | 2023 | Investigation of secretoneurin as a potential biomarker of brain injury in very preterm infants: A pilot study. | 1 |
| 37933640 | 2023 | [High expression of secretogranin II increases oxaliplatin resistance of colorectal cancer cells]. | 0 |
| 35341274 | 2022 | AGTR1, PLTP, and SCG2 associated with immune genes and immune cell infiltration in calcific aortic valve stenosis: analysis from integrated bioinformatics and machine learning. | 0 |
| 35844556 | 2022 | SCG2: A Prognostic Marker That Pinpoints Chemotherapy and Immunotherapy in Colorectal Cancer. | 6 |
| 35341274 | 2022 | AGTR1, PLTP, and SCG2 associated with immune genes and immune cell infiltration in calcific aortic valve stenosis: analysis from integrated bioinformatics and machine learning. | 0 |
| 35844556 | 2022 | SCG2: A Prognostic Marker That Pinpoints Chemotherapy and Immunotherapy in Colorectal Cancer. | 6 |
| 34160138 | 2021 | Secretogranin II impairs tumor growth and angiogenesis by promoting degradation of hypoxia-inducible factor-1α in colorectal cancer. | 15 |
Citation
Dessen P
SCG2 (secretogranin II)
Atlas Genet Cytogenet Oncol Haematol. 2007-02-01
Online version: http://atlasgeneticsoncology.org/gene/43777/scg2
